At a Glance
Dosage
Only in Efavirenz
smoked
| Level | Dose |
|---|---|
| Common | 600–1800 mg |
Only in 25B-NBOMe
insufflated
| Level | Dose |
|---|---|
| Threshold | 25 µg |
| Light | 50–200 µg |
| Common | 200–350 µg |
| Strong | 350–500 µg |
sublingual
| Level | Dose |
|---|---|
| Threshold | 50 µg |
| Light | 100–300 |
Duration
Only in Efavirenz
smoked
Peak
Afterglow
Onset1 min – 5 min
Peak1 hrs – 2 hrs
Afterglow6 hrs – 12 hrs
Only in 25B-NBOMe
sublingual
Total: 8 hrs – 12 hrsEffects
Safety
Interaction: Efavirenz + 25B-NBOMe
Low Risk & Synergy
Cross-tolerance exists; effects compound
Efavirenz — Dangerous Interactions
No dangerous interactions recorded.
25B-NBOMe — Dangerous Interactions
No dangerous interactions recorded.
Frequently Asked Questions
What is the difference between Efavirenz and 25B-NBOMe?
Efavirenz is classified as a Psychedelic (Benzoxazine) while 25B-NBOMe is classified as a Psychedelic (Substituted phenethylamines). They share 23 effects in common, with 18 effects unique to Efavirenz and 19 unique to 25B-NBOMe.
Is it safe to combine Efavirenz and 25B-NBOMe?
The interaction between Efavirenz and 25B-NBOMe is classified as "Low Risk & Synergy". Cross-tolerance exists; effects compound Always research interactions thoroughly before combining any substances.
Which is stronger, Efavirenz or 25B-NBOMe?
Efavirenz and 25B-NBOMe are typically administered via different routes, making a direct potency comparison difficult. They belong to different pharmacological profiles and should not be compared by dose alone.